Alpha-enolase plasminogen receptor in myogenesis.

Plasmin is a potent extracellular protease specialized in the degradation of fibrin (fibrinolysis). Active plasmin is generated by proteolytic activation of the zymogen plasminogen (Plg) by urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA). Alpha-enolase, although traditionally considered a glycolytic enzyme, constitutes a receptor for plasminogen on several cell types, serving to localize and promote plasminogen activation pericellularly. Localization of plasmin activity on the cell surface plays a critical role in fibrinolysis and in physiopathological processes involving extracellular matrix remodelling. Previous studies have unambiguously demonstrated that uPA-dependent plasmin generation is necessary for myogenesis in vitro and for muscle regeneration in vivo. However, the implication of alpha-enolase plasminogen receptor in myogenesis had never been investigated. This review focuses on the recently reported expression and function of alpha-enolase plasminogen receptor during myogenesis. Skeletal myoblasts express alpha-enolase plasminogen receptor, being its expression greatly induced during the differentiation process in vitro. MAb 11G1, a monoclonal antibody against anti-alpha-enolase plasminogen receptor, that inhibits plasmin generation, was able to fully abrogate myoblast fusion and differentiation. Moreover, both plasmin activity and alpha-enolase plasminogen receptor expression were significantly augmented in injury-induced regenerating muscle of wild type mice and in the dystrophic muscle of mdx mice, an animal model of Duchenne muscular dystrophy (DMD). Altogether, these results indicate that the plasminogen activation (PA) system is an important component of skeletal myogenesis in vitro and in vivo. In particular, the expression of alpha-enolase plasminogen receptor may serve to concentrate and enhance plasmin generation on the cell surface of migratory myoblasts contributing to efficient muscle repair.

[1]  P. Muñoz-Cánoves,et al.  Plasmin generation dependent on α-enolase-type plasminogen receptor is required for myogenesis , 2003, Thrombosis and Haemostasis.

[2]  Jordi Félez,et al.  Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α‐Enolase , 2003, American journal of hematology.

[3]  P. Carmeliet,et al.  uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.

[4]  P. Carmeliet,et al.  Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. , 2002, Blood.

[5]  V. Pancholi,et al.  Multifunctional α-enolase: its role in diseases , 2001, Cellular and Molecular Life Sciences CMLS.

[6]  V. Ellis,et al.  Cellular mechanisms regulating non-haemostatic plasmin generation. , 2001, Biochemical Society transactions.

[7]  P. Carmeliet,et al.  Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. , 2001, Blood.

[8]  L. Miles,et al.  Purification, Cloning, and Characterization of a Profibrinolytic Plasminogen-binding Protein, TIP49a* , 2001, The Journal of Biological Chemistry.

[9]  G. Barlovatz-Meimon,et al.  Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. , 2000, Experimental cell research.

[10]  K. Hajjar,et al.  Annexin II and Regulation of Cell Surface Fibrinolysis , 2000, Annals of the New York Academy of Sciences.

[11]  A. Subramanian,et al.  Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. , 2000, The Journal of biological chemistry.

[12]  Y. Nagamine,et al.  The plasminogen activator system: biology and regulation , 1999, Cellular and Molecular Life Sciences CMLS.

[13]  A. Mondino,et al.  Structure and Function of the Urokinase Receptor , 1999, Thrombosis and Haemostasis.

[14]  F. Blasi Proteolysis, Cell Adhesion, Chemotaxis, and Invasiveness Are Regulated by the u-PA-u-PAR-PAI-1 System , 1999, Thrombosis and Haemostasis.

[15]  P. Carmeliet,et al.  Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[16]  V. Fischetti,et al.  α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci* , 1998, The Journal of Biological Chemistry.

[17]  J. Piatigorsky,et al.  Multifunctional Lens Crystallins and Corneal Enzymes: More than Meets the Eye , 1998, Annals of the New York Academy of Sciences.

[18]  M. Leibovitch,et al.  Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. , 1997, Journal of cell science.

[19]  P. Muñoz-Cánoves,et al.  Inhibition of Urokinase-type Plasminogen Activator (uPA) Abrogates Myogenesis In Vitro , 1997, Thrombosis and Haemostasis.

[20]  M. Grounds,et al.  Macrophages and dendritic cells in normal and regenerating murine skeletal muscle , 1997, Muscle & nerve.

[21]  Bonnie F. Sloane,et al.  Gene trapping in differentiating cell lines: regulation of the lysosomal protease cathepsin B in skeletal myoblast growth and fusion , 1996, The Journal of cell biology.

[22]  V. Ellis Functional Analysis of the Cellular Receptor for Urokinase in Plasminogen Activation , 1996, The Journal of Biological Chemistry.

[23]  R. Strieter,et al.  Endogenously produced urokinase amplifies tumor necrosis factor‐α secretion by THP‐1 mononuclear phagocytes , 1996, Journal of leukocyte biology.

[24]  A. Keller,et al.  Differential expression of alpha- and beta-enolase genes during rat heart development and hypertrophy. , 1995, American Journal of Physiology.

[25]  Y. Nabeshima,et al.  A metalloprotease-disintegrin participating in myoblast fusion , 1995, Nature.

[26]  P. Carmeliet,et al.  Gene Targeting and Gene Transfer Studies of the Biological Role of the Plasminogen/Plasmin System , 1995, Thrombosis and Haemostasis.

[27]  J. Hoover-Plow,et al.  The cell biology of the plasminogen system , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  P. Holland,et al.  Synthesis and secretion of matrix‐degrading metalloproteases by human skeletal muscle satellite cells , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[29]  Kanefusa Kato,et al.  Plasminogen Binds Specifically to α‐Enolase on Rat Neuronal Plasma Membrane , 1994 .

[30]  K. Hajjar,et al.  An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. , 1994, The Journal of biological chemistry.

[31]  R. López-Alemany,et al.  Purification of the plasmin receptor from human carcinoma cells and comparison to α-enolase , 1994 .

[32]  Jordi Félez,et al.  Competition between plasminogen and tissue plasminogen activator for cellular binding sites. , 1993, Blood.

[33]  J. B. Rattner,et al.  Enolase is present at the centrosome of HeLa cells. , 1992, Experimental cell research.

[34]  J. Brewer,et al.  Characterization of the interaction of yeast enolase with polynucleotides. , 1992, Biochimica et biophysica acta.

[35]  J. Keski‐Oja,et al.  Enhanced production of plasminogen activator activity in human and murine keratinocytes by transforming growth factor-beta 1. , 1992, The Journal of investigative dermatology.

[36]  F. Gros,et al.  Activation of the gene encoding the glycolytic enzyme β-enolase during early myogenesis precedes an increased expression during fetal muscle development , 1992, Mechanisms of Development.

[37]  F. Blasi,et al.  Modulation of activities and RNA level of the components of the plasminogen activation system during fusion of human myogenic satellite cells in vitro. , 1992, Developmental biology.

[38]  M. Reddy,et al.  Investigation of lens glycolytic enzymes: species distribution and interaction with supramolecular order. , 1992, Experimental eye research.

[39]  H. Lijnen,et al.  Basic and Clinical Aspects of Fibrinolysis and Thrombolysis , 1991 .

[40]  J. B. Rattner,et al.  Autoantibodies to the centrosome (centriole) react with determinants present in the glycolytic enzyme enolase. , 1991, Journal of immunology.

[41]  Jordi Félez,et al.  Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. , 1991, Biochemistry.

[42]  G. Barlovatz-Meimon,et al.  Slow and fast rat skeletal muscles differ in their plasminogen activator activities. , 1990, European journal of cell biology.

[43]  H. Blau,et al.  Migration of myoblasts across basal lamina during skeletal muscle development , 1990, Nature.

[44]  H. Knull,et al.  Glycolytic enzyme interactions with tubulin and microtubules. , 1989, Biochimica et biophysica acta.

[45]  J. Piatigorsky,et al.  Recruitment of enzymes as lens structural proteins. , 1987, Science.

[46]  J. Plescia,et al.  The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type , 1986, The Journal of cell biology.

[47]  M. Herman,et al.  Electron‐immunocytochemical localization of neuron‐specific enolase in cytoplasm and on membranes of primary and metastatic cerebral tumours and on glial filaments of glioma cells , 1986, Histopathology.

[48]  H. Young,et al.  Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. , 1986, Journal of immunology.

[49]  W. Strittmatter,et al.  Rat myoblast fusion requires metalloendoprotease activity , 1983, Cell.

[50]  M. Hoylaerts,et al.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. , 1982, The Journal of biological chemistry.

[51]  R. Lasek,et al.  Nerve-specific enolase and creatine phosphokinase in axonal transport: soluble proteins and the axoplasmic matrix , 1981, Cell.

[52]  R. Miskin,et al.  Plasminogen activator in chick embryo muscle cells: Induction of enzyme by RSV, PMA and retinoic acid , 1978, Cell.

[53]  G. Butler-Browne,et al.  The muscle-specific enolase is an early marker of human myogenesis , 2004, Journal of Muscle Research & Cell Motility.

[54]  P. Muñoz-Cánoves,et al.  Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis. , 2003, Thrombosis and haemostasis.

[55]  V. Pancholi,et al.  Multifunctional alpha-enolase: its role in diseases. , 2001, Cellular and molecular life sciences : CMLS.

[56]  S. Lachkar,et al.  Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. , 1999, Developmental biology.

[57]  E. Plow,et al.  The role of an enolase-related molecule in plasminogen binding to cells. , 1995, European journal of biochemistry.

[58]  R. López-Alemany,et al.  Purification of the plasmin receptor from human carcinoma cells and comparison to alpha-enolase. , 1994, Thrombosis research.

[59]  S. Kohsaka,et al.  Plasminogen binds specifically to alpha-enolase on rat neuronal plasma membrane. , 1994, Journal of neurochemistry.